Randomized, controlled trial of a protein-calorie supplement for women coinfected with HIV-TB

Int J Tuberc Lung Dis. 2022 Aug 1;26(8):798-800. doi: 10.5588/ijtld.21.0669.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Coinfection* / drug therapy
  • Dietary Supplements
  • Female
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Tuberculosis* / complications
  • Tuberculosis* / drug therapy

Substances

  • Antitubercular Agents

Associated data

  • ClinicalTrials.gov/NCT01635153